Studies
Targeting Myeloid-Derived Suppressor Cells in Patients with Recurrent/Progressive Grade 4 Glioma: Phase 1 Trial of Sitagliptin
Cancer
Brain and Spinal Cord Cancer
Adult Subjects
Female Subjects
Male Subjects